Seeing Is Believing
Healthcare - Sector
MYGN is currently covered by 7 analysts with an average price target of $6.42. This is a potential upside of $2.14 (50%) from yesterday's end of day stock price of $4.28.
Myriad Genetics's activity chart (see below) currently has 221 price targets and 181 ratings on display. The stock rating distribution of MYGN is 83.33% HOLD and 16.67% BUY.
Analysts average stock forecasts to be materialized ratio is 66.73% with an average time for these price targets to be met of 153.89 days.
Highest price target for MYGN is $9, Lowest price target is $3, average price target is $6.42.
Most recent stock forecast was given by JOHN WILKIN from CRAIG HALLUM on 01-Oct-2026. First documented stock forecast 30-May-2013.
Currently out of the existing stock ratings of MYGN, 10 are a HOLD (83.33%), 2 are a BUY (16.67%).
3/26/09 2 for 1
9/12/00 2 for 1
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2025
$8
$3.46 (76.21%)
$18
6 days ago
(01-Oct-2026)
0/3 (0%)
$3.46 (76.21%)
Hold Since 09-Dec-2024
$3.6
$-0.94 (-20.70%)
$6
29 days ago
(08-Sep-2026)
4/6 (66.67%)
$0.41 (12.85%)
66
Hold Since 05-Oct-2022
$3
$-1.54 (-33.92%)
1 months 20 days ago
(17-Aug-2026)
3/3 (100%)
$0.13 (4.53%)
193
Hold Since 05-May-2026
$4
$-0.54 (-11.89%)
$6
2 months 7 days ago
(30-Jul-2026)
2/2 (100%)
$1.14 (39.86%)
52
Hold Since 24-Feb-2026
$5.5
$-0.38 (-6.46%)
$6
5 months 1 days ago
(06-May-2026)
13/14 (92.86%)
$1.39 (33.82%)
124
What is MYGN (Myriad Genetics) average time for price targets to be met?
Which analyst most recently updated their price target on MYGN (Myriad Genetics)?
Which analyst has the most public recommendations on MYGN (Myriad Genetics)?
Which analyst is the currently most bullish on MYGN (Myriad Genetics)?
Which analyst is the currently most reserved on MYGN (Myriad Genetics)?